CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 87,665 enrolled
Drug / intervention
4 Pillars Immunization Toolkitbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01664793
NCT01664793N/ACompleted
CompareCT.gov

From Innovation to Solutions: Autodialers, Use of Early Autumn Physicals and Vaccination Assessment as a Vital Sign to Increase Childhood Influenza Vaccination in Diverse Settings

University of Pittsburgh·interventional·Posted Aug 14, 2012·Updated Nov 24, 2014

In Brief

A clinical study evaluating 4 Pillars Immunization Toolkit for Influenza. Completed, enrolled 87,665 participants across 1 site.

Detailed Summary

The purpose of this study is to increase childhood influenza vaccination rates using the FDA licensed influenza vaccines according to national guidelines in a randomized cluster trial in which primary care offices are randomized to intervention or control with the control group receiving the intervention in the second year.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedAug 14, 2012
Enrollment StartOct 1, 2010
Primary CompletionFeb 1, 2013
Study CompletionNov 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 13.9 years ago

Interventions

4 Pillars Immunization Toolkitbehavioral

Pillar 1: Convenient Vaccination Services; Pillar 2: Patient notification about the importance of vaccination and availability of convenient services; Pillar 3: Enhanced Office Systems; Pillar 4: Motivation: Office immunization champion tracks progress towards a goal; Early delivery of donated vaccines for disadvantaged children, staff education, support of effort by research staff.